Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.84 +0.48 (+2.48%)
As of: Oct 20, 2026 · 3:59 PM EDT

Amneal Pharmaceuticals (AMRX) Cash from Restructuring (2018 - 2021)

Updated

Amneal Pharmaceuticals (AMRX) recorded Cash from Restructuring of $11.3 million in FY2018.

Analysis

Amneal Pharmaceuticals (AMRX) Cash from Restructuring (2018 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Amneal Pharmaceuticals 6.34 Bn 5.53 Bn 334.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -788,000.00
Sep 30, 2021 425,000.00
Dec 31, 2020 -3.19 Mn
Sep 30, 2020 276,000.00
Jun 30, 2020 333,000.00
Dec 31, 2019 -17.47 Mn
Sep 30, 2019 20.94 Mn
Jun 30, 2019 2.84 Mn
Dec 31, 2018 11.30 Mn
API Access

Amneal Pharmaceuticals Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=AMRX&period=max&api_key=YOUR_API_KEY